Intellectual Property India Publishes Patent Application for 'Reduced Dose Metaxalone Formulations' Filed by Primus Pharmaceuticals, Inc.

MUMBAI, India, Sept. 26 -- Intellectual Property India has published a patent application (202524027421 A) filed by Primus Pharmaceuticals, Inc., Scottsdale, U.S.A., on March 24, for 'reduced dose metaxalone formulations.'

Inventor(s) include Mukteeshwar Gande; Robert M. Levy; Sam G. Salamone; and Trevor T. Hall.

The application for the patent was published on Sept. 26, under issue no. 39/2025.

According to the abstract released by the Intellectual Property India: "Oral dosage forms of metaxalone having improved bioavailability in the fed and fasted states, including dosage forms that employ a reduced dose based on such improved bioavailability."

Disclaimer: Curated by HT Syndication.